Jazz Pharmaceuticals plc
JAZZ
$103.58
$5.805.93%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -148.42% | -11.13% | 27.58% | 1,253.15% | -115.53% |
| Total Depreciation and Amortization | -2.10% | 1.93% | 1.35% | -0.21% | 2.63% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -41.55% | 165.33% | 68.86% | -57.21% | -34.66% |
| Change in Net Operating Assets | 460.19% | -202.98% | 1.58% | -147.53% | 131.16% |
| Cash from Operations | 7.83% | -0.04% | 20.34% | 24.00% | 59.69% |
| Capital Expenditure | -4.47% | -23.16% | -52.14% | -2.71% | 31.66% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 13.86% | -180.04% | 189.95% | 5.66% | -336.82% |
| Cash from Investing | 12.60% | -190.28% | 183.27% | 5.45% | -367.10% |
| Total Debt Issued | -- | -100.00% | -- | -- | -- |
| Total Debt Repaid | -9,677.42% | 98.67% | -7,419.35% | 0.00% | 0.00% |
| Issuance of Common Stock | 24.48% | 53,994.12% | -99.84% | 2,114.57% | -94.42% |
| Repurchase of Common Stock | -1,576.98% | 97.36% | 7.71% | -233.24% | 51.39% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -9,730.40% | -103.36% | 252.98% | -184.84% | 43.62% |
| Foreign Exchange rate Adjustments | 174.05% | -174.54% | 504.61% | 55.30% | -194.91% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -382.92% | -77.42% | 1,084.59% | -39.19% | -136.88% |